Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus

Diabetology & Metabolic Syndrome20102:57

https://doi.org/10.1186/1758-5996-2-57

  • Received: 24 August 2010
  • Accepted: 25 August 2010
  • Published:

The original article was published in Diabetology & Metabolic Syndrome 2010 2:16

Correction

Since publication of our article [1], we have noticed that amendments to the second sentence of the "Study Design" section are required as this should read as follows:

"Approved by the local ethics committee, patient enrolment was restricted to the following patients: those aged 18 years and greater and taking immediate release metformin alone or in combination with other oral agents, those excluded had symptoms of poor diabetes control, were pregnant, had serum creatinine levels >1.3 mg/dL (female) or 1.4 mg/dL (male), nephropathy, evidence of hepatic disease or history of alcohol abuse."

We apologize for any inconvenience or confusion that this may have caused.

Notes

Authors’ Affiliations

(1)
Department of Medicine, Diabetes Unit, State University of Rio de Janeiro, Rio de Janeiro, Brazil

References

  1. Levy J, Cobas RA, Gomes MB: Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus. Diabetol Metab Syndr. 2010, 2: 16-10.1186/1758-5996-2-16.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

Advertisement